Vyant Bio (VYNT)
US Market

Vyant Bio (VYNT) Cash flow


Vyant Bio Cash Flow

VYNT's free cash flow for Q4 2022 was $-3.30M. For the 2022 fiscal year, VYNT's free cash flow was decreased by $3.18M and operating cash flow was $-3.29M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20
Operating Cash Flow
$ -13.91M$ -13.68M$ -16.99M$ -5.81M
Investing Cash Flow
$ 3.27M$ 3.26M$ 29.62M$ -43.00K
Financing Cash Flow
$ -139.00K$ -149.00K$ 7.19M$ 6.33M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 48.82M$ 10.04M$ 20.61M$ 792.00K
Income Tax Paid Supplemental Data
$ 8.00K$ 8.00K-$ 1.00K
Interest Paid Supplemental Data
$ 34.00K$ 34.00K$ 8.00K$ 5.00K
Issuance Of Capital Stock
$ 58.00K$ -188.00K$ 41.00K$ 1.35M
Issuance Of Debt
$ 72.00K-$ 4.94M$ 5.06M
Repayment Of Debt
$ -131.00K-$ -82.00K$ -76.00K
Free Cash Flow
$ -14.53M$ -14.30M$ -17.48M$ -5.87M
Domestic Sales
Foreign Sales
Currency in USD

Vyant Bio Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis